Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. - Wikidata - wikimedia - TriplyDB

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

http://www.wikidata.org/entity/Q51940628

about

Update on treatment of light chain amyloidosis Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain Amyloidosis and POEMS syndrome.Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial Amyloidosis: pathogenesis and new therapeutic options.High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65.A prospective study of nutritional status in immunoglobulin light chain amyloidosis.Autologous stem cell transplantation and IgM amyloidosis.Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction Perspectives in treatment of AL amyloidosis.Incidence, diagnosis and prognosis of cardiac amyloidosis.The burden of amyloid light chain amyloidosis on health-related quality of life.Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.The patient's perspective on the symptom and everyday life impact of AL amyloidosis.Disease burden of systemic light-chain amyloidosis: a systematic literature review.A clinical staging score to measure the severity of dialysis-related amyloidosis.Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.Vertebra collapse due to primary amyloidosis causing neurological compromise.Autologous stem cell transplant for Al amyloidosis.Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study.Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples.Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients.Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis.Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.Abstracts A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year

P2860

Q26829735-353E86AA-47BD-4B98-ACAA-99F9E57A1409 Q28304712-1813231E-E3E8-40A1-AEF0-96FD77471633 Q33304297-DD17EDEE-BC13-48F3-80F2-75BA1B49D472 Q33840466-CB27517A-A976-438F-820C-23E92706BA53 Q33867198-CF1603E4-E9C1-4586-9B3D-FB941A405315 Q34482518-621BB129-B559-485E-9D6B-14252DBD897C Q35081363-34732C0C-AD11-40B7-ADE6-865F752383A7 Q35111771-E8BF5BE8-3951-47D9-91D9-DFAEB85A56AC Q35750326-AE7521DF-2348-4405-A7F4-3B6183325367 Q35848844-9B74E70D-5763-4B1A-A000-CB7305D9FE20 Q36498408-6AC978B9-C2BE-4463-8523-5736F9B25046 Q36535491-694B3D68-C476-4621-891C-EC2BB1B82957 Q36901282-581DE60A-8262-4A1A-8C01-9422412A70A0 Q37045885-4FCD91AC-6FDE-444B-9123-ACBBD227BF9A Q37399628-EA3EFD59-328A-4E5B-A559-7F48E681DE4B Q37593524-7232FC57-BD45-4D5E-B134-70C544030BB4 Q37904673-07845119-9499-41CA-90BE-C3228DBD73CF Q37995198-C744A543-E17E-4286-A755-6E01D32DC360 Q37999957-10233A4D-7D55-4D9F-8DEC-18989135D9E4 Q38639919-44110ED6-38D5-4C91-820B-5375147CDBC2 Q38917828-75BBE00B-5A6A-41B7-98EC-03AC5B04D735 Q39658631-2FC45BFD-C254-4363-9798-05BF81D26E1C Q40343246-6BE0B2A2-00FB-435D-B60F-EBF9F258A0A4 Q41723913-C12004CF-697B-4D23-B8A1-4D0AC99C79D8 Q41822878-3AD692BD-7BB1-4435-AB6A-F46A6D39FA0C Q42179759-6C34D6C6-8927-4E67-AECC-178168E22730 Q42907761-819497F0-C0C7-45FD-AA09-D642656851B6 Q44248482-B7C58787-291A-40DF-A13C-34BBE3743199 Q46980729-96D28039-C542-4298-9B86-9C73DF53DE9F Q47096627-C2A99BC2-27C9-4BD0-A34A-2EFD30CEF3F7 Q47160869-573D7EEA-CEB5-410A-B377-F5C2DAFA2FC5 Q47383265-A1F9F2DB-45C2-4C7E-9F39-220B4297317A Q48615482-03FA7978-4E65-4F83-9CB5-0759F9B4071F Q51389775-5DCEEFE8-A672-4A68-A489-CA506F77BCB4 Q53504425-7ACA6F3A-A680-41BA-9242-A3094496C891 Q57259399-DD2EE09E-73DA-4AAE-9712-40D948D1ADB3 Q58275488-D6E1AAD4-99D1-4A43-B078-FF80A5B5FC1E

P2860

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

http://www.wikidata.org/entity/Q51940628

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Improvement in quality of life ...... ous stem cell transplantation.

@en

Improvement in quality of life ...... ous stem cell transplantation.

@nl

type

label

Improvement in quality of life ...... ous stem cell transplantation.

@en

Improvement in quality of life ...... ous stem cell transplantation.

@nl

prefLabel

Improvement in quality of life ...... ous stem cell transplantation.

@en

Improvement in quality of life ...... ous stem cell transplantation.

@nl

P1433

Q51940628-7195C465-5AE4-425E-BF5B-5F274BB451D2

P1476

Q51940628-14A66191-166F-4075-A68E-E1D9438E8CB1

P2093

Q51940628-2166E8D0-A51C-48E5-9432-ACEEAAC9C058

Q51940628-669FD7A6-A96D-4786-AB14-699FB43070DE

Q51940628-8687CD0B-673B-430A-B38B-F3FDAE2DB1E6

Q51940628-8893DC90-5C2C-4C00-9D32-13A4457CCF9C

Q51940628-90103989-2465-411A-92BE-C01ED5185464

Q51940628-9E812859-163C-4BD4-84F2-740B00D95BBE

Q51940628-A69E252A-9A47-4109-9C77-E910F3EF0402

Q51940628-A9145F30-D08E-48FE-AEF6-9FB92E70C241

P304

Q51940628-B7D1F07A-6600-46CE-AB72-07728802647E

P31

Q51940628-5428797A-2240-464E-979E-AC1942BE0525

P356

Q51940628-2C82997E-5394-4950-B2AE-B02D84126B72

P407

Q51940628-D5D9289A-F676-4E26-9AC2-45C173395B7C

P433

Q51940628-38C01D2C-CB4C-49CB-BE80-61B66A3DCACB

P478

Q51940628-46C89A61-D20D-4E8F-A0E0-94EF7DF51372

P50

Q51940628-1B67EA46-944C-45D7-8ECA-51923743CBDA

Q51940628-88A648D5-BA7B-4DA1-8F81-0FC19D6B3191

Q51940628-89AA83AA-96BB-4BDD-B326-7624E998C5FF

P577

Q51940628-4F46DEB7-F6CE-4919-AA57-76A67534B414

P5875

Q51940628-079CAAE9-4F3B-4121-AB78-45A9520C9DC3

P698

Q51940628-5014C711-71CB-463A-A4D2-0A5510B0C03E

P921

Q51940628-74B40D2E-EB97-474E-B8DD-FB137F83925B

P356

BLOOD-2004-01-0089

P1433

P1476

Improvement in quality of life ...... ous stem cell transplantation.

@en

P2093

Daniel G Wright

http://www.w3.org/2001/XMLSchema#string

David C Seldin

http://www.w3.org/2001/XMLSchema#string

Jennifer J Anderson

http://www.w3.org/2001/XMLSchema#string

Karim Malek

http://www.w3.org/2001/XMLSchema#string

Kathleen T Finn

http://www.w3.org/2001/XMLSchema#string

Laura M Dember

http://www.w3.org/2001/XMLSchema#string

Martha Skinner

http://www.w3.org/2001/XMLSchema#string

Rodney H Falk

http://www.w3.org/2001/XMLSchema#string

P304

1888-1893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2004-01-0089

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Vaishali Sanchorawala

P577

2004-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8551797

http://www.w3.org/2001/XMLSchema#string

P698

15155460

http://www.w3.org/2001/XMLSchema#string

P921

quality of life